Analysis of USP14 expression in the TCGA or CGGA glioma dataset revealed that increased expression of USP14 correlated with glioma tumor progression (Figure 1H), with MES compared with CL and PN GBM subtypes (Figure 1I), and with decreased patient survival (Figure 1J-K). This evidence concerns the gene USP14 and central nervous system cancer.